Immunogenicity, drug trough levels and therapeutic response in patients with rheumatoid arthritis or ankylosing spondylitis after 24-week golimumab treatment
- PMID: 26443609
- DOI: 10.1136/annrheumdis-2015-207978
Immunogenicity, drug trough levels and therapeutic response in patients with rheumatoid arthritis or ankylosing spondylitis after 24-week golimumab treatment
Keywords: Ankylosing Spondylitis; Anti-TNF; Rheumatoid Arthritis.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials